Biofrontera Inc. (BFRI) Balance Sheet

NASDAQ: BFRIAssets, liabilities, debt and equity over 7 years.

BFRI balance sheet, 2025

December 31, 2025 · U.S. dollars

$28.6M assets = $18.1M liabilities + $10.5M equity

What it owns$28.6MCash & ST investments: $6.4M (22.4%)Cash & ST investments$6.4M · 22%Receivables: $7.3M (25.5%)Receivables$7.3M · 26%Inventory: $1.4M (5.0%)Other current: $3.0M (10.4%)Other current $3.0MPP&E: $3.7M (13.1%)PP&E$3.7M · 13%Goodwill & intangibles: $2.6M (9.3%)$2.6MOther non-current: $4.1M (14.3%)Other non-current$4.1M · 14%=How it is financed$28.6MCurrent liabilities: $11.9M (41.6%)Current liabilities$11.9M · 42%Long-term debt: $4.6M (16.1%)Long-term debt$4.6M · 16%Other LT liabilities: $1.6M (5.6%)Shareholders’ equity: $10.5M (36.7%)Shareholders’ equity$10.5M · 37%

Both columns are drawn to the same scale: what BFRI owns equals what it owes plus shareholders’ equity. Hover a block for its value.

BFRI financial health

Current ratio1.52
Comfortable · current assets cover current liabilities 1.52×
Debt / equity0.59
Moderate leverage · $0.59 of debt for each $1 of equity
Equity / assets36.7%
Balanced · of assets funded by shareholders
Cash / debt103.7%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles9.3%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

BFRI balance sheet trends, 2019–2025

Biofrontera Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$28.8M2019$28.6M2025−0.1%/yr
Total liabilities$58.9M2019$18.1M2025−17.9%/yr
Shareholders’ equity−$30.2M2019$10.5M2025—
Cash & short-term investments$7.3M2019$6.4M2025−2.2%/yr
Total debt$38.2M2019$6.2M2025−26.2%/yr
Net cash (debt)−$30.9M2019$231,0002025+$31.1M
Working capital$11.7M2019$6.2M2025−$5.5M
Book value per share$0.802024$0.902025+12.0%/yr
Current ratio2.0020191.522025−0.48
Debt / equity0.5920210.5920250.00
Shares outstanding5.5M202411.6M2025+111.2%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

BFRI assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

BFRI liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

BFRI debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

BFRI balance sheet

Biofrontera Inc. annual balance sheet
2025202420232022202120202019
Assets
Cash & short-term investments$6.4M$5.9M$1.4M$27.8M$24.5M$8.1M$7.3M
Cash & equivalents$6.4M$5.9M$1.3M$17.2M$24.5M$8.1M$7.3M
Short-term investments$9,000$7,000$78,000$10.5M$0——
Receivables$7.3M$5.3M$5.2M$7.4M$3.8M$3.3M$4.8M
Inventory$1.4M$6.6M$10.9M$7.2M$4.5M$7.1M$10.5M
Other current assets$3.0M$2.8M$5.6M$810,000$13.6M$1.1M$900,000
Total current assets$18.1M$20.7M$23.1M$43.1M$46.4M$19.6M$23.5M
Property, plant & equipment (net)$3.7M$983,000$1.7M$1.6M$267,000$370,000$503,000
Goodwill & intangible assets$2.6M$35,000$2.6M$3.0M$3.5M$3.9M$4.3M
Long-term investments$0$0$0$0$0$0$0
Other non-current assets$4.1M$383,000$482,000$3.1M$3.1M$323,000$494,000
Total assets$28.6M$22.1M$27.9M$50.9M$53.2M$24.1M$28.8M
Liabilities
Accounts payable$1.9M$1.9M$8.9M$1.3M$658,000$1.5M$7.8M
Short-term debt$332,000$548,000$4.6M$498,000$6.7M——
Deferred revenue——$27,000$6.9M$3.2M——
Total current liabilities$11.9M$12.0M$18.1M$20.9M$13.8M$4.4M$11.7M
Long-term debt$4.6M$4.1M$0$0$0$0$38.2M
Lease obligations$1.6M$824,000$1.5M$1.3M$0——
Other long-term liabilities$1.6M$1.5M$5.1M$6.1M$28.0M$13.9M$9.0M
Total liabilities$18.1M$17.7M$23.1M$27.0M$41.9M$18.3M$58.9M
Shareholders' equity
Common stock & paid-in capital$12,000$9,000$2,000$1,000$17,000$8,000—
Retained earnings (deficit)−$127.9M−$117.4M−$99.7M−$79.5M−$78.9M−$41.2M−$30.2M
Accumulated other comprehensive income————$0——
Total shareholders' equity$10.5M$4.4M$4.8M$23.9M$11.3M$5.8M−$30.2M
Key figures
Total debt$6.2M$4.9M$5.4M$1.3M$6.7M—$38.2M
Net cash (debt)$231,000$990,000−$4.0M$26.4M$17.9M—−$30.9M
Working capital$6.2M$8.7M$5.0M$22.2M$32.6M$15.2M$11.7M
Tangible book value$7.8M$4.4M$2.2M$20.8M$7.9M$2.0M−$34.5M
Book value per share$0.90$0.80—————
Shares outstanding11.6M5.5M—————
Current ratio1.521.721.282.063.364.432.00
Quick ratio1.150.930.361.682.052.571.03
Debt / equity0.591.111.130.060.59——
Equity / assets36.7%20.1%17.2%46.9%21.3%24.1%−105.0%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 19, 2026); data from EODHD.

BFRI financial position

At the end of fiscal 2025 (December 31, 2025), Biofrontera had total assets of $28.6 million (up 29.2% from a year earlier), total liabilities of $18.1 million and shareholders' equity of $10.5 million. It held $6.4 million in cash and short-term investments against $6.2 million of debt, a net cash position of $0.2 million. Its current ratio was 1.52. In the latest quarter (ended June 30, 2026) total assets were $24.1 million and equity $6.0 million.

Related: BFRI income statement, BFRI cash flow statement, BFRI key metrics. See the BFRI stock overview for the latest quote and news.

BFRI balance sheet FAQ

What are Biofrontera's total assets?

Biofrontera reported total assets of $28.6 million at the end of fiscal 2025 (December 31, 2025), compared with $22.1 million a year earlier.

How much debt does Biofrontera have?

Biofrontera had $6.2 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.59.

How much cash does Biofrontera have?

Biofrontera held $6.4 million in cash and short-term investments at the end of fiscal 2025; with $6.2 million of debt that is net cash of $0.2 million.

What is Biofrontera's book value?

Biofrontera's shareholders' equity (book value) was $10.5 million at the end of fiscal 2025, or $0.90 per share.

What is Biofrontera's current ratio?

Biofrontera had current assets of $18.1 million and current liabilities of $11.9 million, a current ratio of 1.52 (it can cover its short-term obligations).

How much goodwill does Biofrontera have?

Biofrontera carried $2.6 million of goodwill and intangible assets, 9.3% of total assets, at the end of fiscal 2025.

Drug Manufacturers - Specialty & Generic: balance sheet